(Q37682546)

22 August 2017

1 reference

title

Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men. (English)

1 reference

22 August 2017

1 reference

Ethel S Siris

1

1 reference

22 August 2017

Sanford Baim

series ordinal

2

1 reference

22 August 2017

Aurelia Nattiv

series ordinal

3

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

22 August 2017

published in

Postgraduate Medicine

1 reference

22 August 2017

volume

122

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

82-90

1 reference

Osteoporosis epidemiology update

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Cost-effective osteoporosis treatment thresholds: the United States perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Osteoporosis prevention, diagnosis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Prevalence of low femoral bone density in older U.S. adults from NHANES III.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Bone mineral density thresholds for pharmacological intervention to prevent fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Clinical practice. Osteopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Hip fracture in women without osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Identification of osteopenic women at high risk of fracture: the OFELY study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

FRAX and the assessment of fracture probability in men and women from the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

FRAX and its applications to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

An approach for identifying postmenopausal women age 50-64 years at increased short-term risk for osteoporotic fracture.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

An assessment tool for predicting fracture risk in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

A meta-analysis of previous fracture and subsequent fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Assessment of fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

BMD and risk of hip and nonvertebral fractures in older men: a prospective study and comparison with older women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Smoking and fracture risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Alcohol intake as a risk factor for fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Updated data on proximal femur bone mineral levels of US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Updated fracture incidence rates for the US version of FRAX.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

A family history of fracture and fracture risk: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

New guidelines for the prevention and treatment of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

FRAX and risk of vertebral fractures: the fracture intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Shifting the focus in fracture prevention from osteoporosis to falls

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Preventing falls: Not at the expense of osteoporosis care

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Second Hip Fracture in Older Men and Women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

The potential impact of new National Osteoporosis Foundation guidance on treatment patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Ten-year fracture probability identifies women who will benefit from clodronate therapy--additional results from a double-blind, placebo-controlled randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Teriparatide in the treatment of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

A New Approach to the Development of Assessment Guidelines for Osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

The population burden of fractures originates in women with osteopenia, not osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

Half the burden of fragility fractures in the community occur in women without osteoporosis. When is fracture prevention cost-effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2102

21 January 2018

Identifiers

DOI

10.3810/PGM.2010.01.2102

1 reference

release_4ar4eeiqtngrdns4s7ivkdog3y

22 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4ar4eeiqtngrdns4s7ivkdog3y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference